Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001493152-26-000376·Injective Foundation
Schedule 13D ownership disclosure
PINEAPPLE FINANCIAL INC
Common Shares, no par value · CUSIP: 72303K405
Event date: 2025-12-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Injective FoundationReported CIK 0002094853
Shares: 9,615,385.00 · Class: 36.99%
- Glenn Kennedy
Shares: 9,615,385.00 · Class: 36.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-26-000376
- Form type
- SCHEDULE 13D
- Filer
- Injective Foundation
- CIK
- CIK 2094853
- Filed
- Jan 05, 2026
- Reporting period
- Dec 30, 2025
- Description
- Schedule 13D beneficial ownership